The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-((S)-2-(4-bromobenzamido)-3-methylbutanoyl)-N-((S)-1-fluoro-6-guanidino-2-oxohexan-3-yl)oxazolidine-4-carboxamide ID: ALA4527787
PubChem CID: 126679424
Max Phase: Preclinical
Molecular Formula: C23H32BrFN6O5
Molecular Weight: 571.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@H](NC(=O)c1ccc(Br)cc1)C(=O)N1COC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)CF
Standard InChI: InChI=1S/C23H32BrFN6O5/c1-13(2)19(30-20(33)14-5-7-15(24)8-6-14)22(35)31-12-36-11-17(31)21(34)29-16(18(32)10-25)4-3-9-28-23(26)27/h5-8,13,16-17,19H,3-4,9-12H2,1-2H3,(H,29,34)(H,30,33)(H4,26,27,28)/t16-,17-,19-/m0/s1
Standard InChI Key: PGLZAAFBGUBOEE-LNLFQRSKSA-N
Molfile:
RDKit 2D
36 37 0 0 0 0 0 0 0 0999 V2000
22.2305 -3.5614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5205 -3.9661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5160 -4.7832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8151 -3.5536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8229 -2.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1182 -2.3238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4073 -2.7285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4054 -3.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1106 -3.9587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7013 -2.3170 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
22.9464 -3.9555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9630 -4.7725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2638 -5.1954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6789 -5.1666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6559 -2.7308 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3148 -2.2519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0659 -1.4735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2487 -1.4697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9927 -2.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0086 -3.4831 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.0161 -2.6680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8190 -5.1398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8114 -5.9549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0985 -6.3534 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7296 -2.2654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4310 -2.6815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1404 -2.2784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4234 -3.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1253 -3.9086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1177 -4.7237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1480 -1.4632 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8448 -2.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5558 -2.2898 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.5144 -6.3717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6547 -3.5479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3618 -3.9576 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 10 1 0
11 1 1 0
11 12 1 6
12 13 1 0
12 14 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 15 1 0
21 25 1 0
27 31 2 0
16 21 1 1
21 20 2 0
22 23 1 0
23 24 2 0
25 26 1 0
26 27 1 0
26 28 1 6
28 29 1 0
29 30 1 0
30 22 1 0
27 32 1 0
32 33 1 0
23 34 1 0
15 35 1 0
35 11 1 0
35 36 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 571.45Molecular Weight (Monoisotopic): 570.1602AlogP: 0.68#Rotatable Bonds: 12Polar Surface Area: 166.71Molecular Species: BASEHBA: 6HBD: 5#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 12.44CX Basic pKa: 11.86CX LogP: 0.60CX LogD: -1.48Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.14Np Likeness Score: -0.23
References 1. Hatcher JM, Du G, Fontán L, Us I, Qiao Q, Chennamadhavuni S, Shao J, Wu H, Melnick A, Gray NS, Scott DA.. (2019) Peptide-based covalent inhibitors of MALT1 paracaspase., 29 (11): [PMID:30954428 ] [10.1016/j.bmcl.2019.03.046 ]